Role of CD28+ PD-1+ Tc cells in immune response and prognosis prediction in hepatocellular carcinoma

Role of CD28+ PD-1+ Tc cells in immune response and prognosis prediction in hepatocellular carcinoma

BackgroundCD28+PD-1+ Tc cells (CD8+ T cells) constitute a dysfunctional subset of T cell; however, the mechanisms underlying their dysfunction and their significance in hepatocellular carcinoma (HCC) remain unclear. We aimed to elucidate the prognostic significance and molecular characteristics of C...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wuhan Yang, Teng Pan, Yaowen Chen, Hao Guo, Yaqi Peng, Chao Wang, Li Peng, Shubin Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Immunology
Subjects:	hepatocellular carcinoma t cell exhaustion CD28 PD-1 single-cell RNA-seq tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1576193/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD8<sup>+</sup>CD28<sup>+</sup>PD1<sup>−</sup> T Cells as a Prognostic Biomarker in Endometrial Cancer
by: Yufei Nie, et al.
Published: (2025-02-01)

PD1+ Treg cell remodeling promotes immune homeostasis within peripheral blood and tumor microenvironment after microparticles-transarterial chemoembolization in hepatocellular carcinoma
by: Zhizhong Ren, et al.
Published: (2025-02-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

Common Ɣ-chain cytokine receptors as functional phenotype markers of PD-1and TIM-3-positive T cells in multiple myeloma
by: E. V. Batorov, et al.
Published: (2023-02-01)

CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance
by: Carolina Abrate, et al.
Published: (2025-12-01)

Enhancing CAR-T Efficacy: The Role of Anti PD-1/PD-L1 Checkpoint Inhibitors in Modern Cancer Treatment
by: Rishi Kant, et al.
Published: (2025-06-01)

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
by: Yuqing Xie, et al.
Published: (2023-02-01)

The potential role of biomarkers CD28 and PF4 in the pathogenesis of idiopathic pulmonary fibrosis and their impact on the prognosis: an immune microenvironment analysis
by: Li Yan, et al.
Published: (2025-06-01)

Expression and relationship of PD-L1, CD24, and CD47 in hepatitis B virus associated hepatocellular carcinoma
by: Aiping Lin, et al.
Published: (2024-12-01)

TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients
by: Zahra Modabber, et al.
Published: (2021-12-01)

CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
by: Hanghang Xie, et al.
Published: (2024-12-01)

Cancer cells accelerate exhaustion of persistently activated mouse CD4+ T cells
by: Malgorzata Stachowiak, et al.
Published: (2025-12-01)

Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
by: Yuxiang Huang, et al.
Published: (2025-01-01)

Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles
by: Jun Deng, et al.
Published: (2023-12-01)

Advances in CAR optimization strategies based on CD28
by: Sijin Li, et al.
Published: (2025-03-01)

Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
by: Carla Fuster-Anglada, et al.
Published: (2025-06-01)

Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
by: Wannakorn Khopanlert, et al.
Published: (2024-09-01)

Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer
by: Lili Jiang, et al.
Published: (2025-06-01)

Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
by: Palak H Mehta, et al.
Published: (2024-01-01)

C-reactive protein induced T cell activation is an indirect monocyte-dependent mechanism involving the CD80/CD28 pathway
by: Julia Thomé, et al.
Published: (2025-07-01)

Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs
by: Lin Xu, et al.
Published: (2024-12-01)

Study of TRAF3IP3 for prognosis and immune infiltration in hepatocellular carcinoma
by: Xing Wang, et al.
Published: (2024-12-01)

Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus
by: Ferdinand Toberer, et al.
Published: (2025-07-01)

Structural and temporal dynamics analysis of PD-1/PD-L1 immunotherapy in hepatocellular carcinoma: History, research hotspots, and emerging trends
by: Talaiti Tuergan, et al.
Published: (2025-12-01)

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)

Deciphering hypoxia’s role in hepatocellular carcinoma prognosis with single-cell approaches
by: Jun Liang, et al.
Published: (2025-07-01)

A novel Tc17 population recruited by tumor cells promotes tumor progression in gastric cancer
by: Yichao Wang, et al.
Published: (2025-05-01)

Serum sPD-1 as a marker of T cell exhaustion in ART-naïve, ART-experienced, and intestinal parasite co-infected HIV-positive adults at the university of Gondar comprehensive specialized hospital, Northwest Ethiopia, 2024
by: Tadelo Wondmagegn, et al.
Published: (2025-05-01)

NECTIN-4-redirected T cell Antigen Coupler T cells bearing CD28 show superior antitumor responses against solid tumors
by: Cheng Wei, et al.
Published: (2024-12-01)

Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
by: Dongjing Zhang, et al.
Published: (2025-01-01)

Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
by: Annapaola Montagner, et al.
Published: (2024-12-01)

Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
by: Tao Zhang, et al.
Published: (2025-04-01)

MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1/PD-L1 therapy in hepatocellular carcinoma
by: Rui Zhang, et al.
Published: (2025-07-01)

MEK inhibitor PD0325901 upregulates CD34 expression in endothelial cells via inhibition of ERK phosphorylation
by: Chihiro Hosoda, et al.
Published: (2024-06-01)

CD28 shapes T cell receptor signaling by regulating Lck dynamics and ZAP70 activation
by: Kumarkrishna Raychaudhuri, et al.
Published: (2024-12-01)

Deficiencies of Inducible Costimulator (ICOS) During Chronic Infection with <i>Toxoplasma gondii</i> Upregulate the CD28-Dependent Cytotoxicity of CD8<sup>+</sup> T Cells and Their Effector Function Against Tissue Cysts of the Parasite
by: Rajesh Mani, et al.
Published: (2024-12-01)

Unveiling B7/CD28 family proteins in hepatocellular carcinoma: insights into communication and prognostic significance
by: Yan Cai, et al.
Published: (2025-07-01)

Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma
by: Hao-Dong QIAO, et al.
Published: (2023-10-01)

Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma
by: Tang M, et al.
Published: (2025-02-01)

An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy
by: Haoran Sun, et al.
Published: (2025-05-01)